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DQ2/8 patients with hsCRP > 1 mg/l showed significantly 
higher levels of plasma MMP-8 than the non-DQ2/8 group.
Conclusions The diabetes-risk genotype DQ2/8 and sys-
temic inflammation contribute to pro-atherosclerotic vascu-
lar changes in children and adolescents with T1D.
Keywords Children · Intima-media thickness · Type 1 
diabetes · Infections · Matrix metalloproteinase-8
Abbreviations
CAC  Carotid artery compliance
cIMT  Carotid artery intima-media thickness
FMD  Flow-mediated dilatation
HLA  Human leucocyte antigen
MMP-8  Matrix metalloproteinase-8
T1D  Type 1 diabetes
Introduction
Increased infection recurrence appears to be independent 
predictor of the risk of developing T1D [1] and impaired 
carotid artery elasticity [2], an index of early atherosclero-
sis [3]. Endothelial cell damage and inflammation are cen-
tral in atherogenesis. Inflammation is involved not only in 
the initiation and progression of atherosclerosis, but also 
in the occurrence of its complications such as myocardial 
infarction and stroke [4]. Both bacterial and viral infections 
correlate to preatherosclerotic changes in the arteries and 
coronary disease [5]. Experimental animal studies have 
more consistently provided evidence for deleterious effects 
of various infectious pathogens on arterial structure [6–8]. 
These effects seem to be more prominent in vessels from 
younger animals, and appear to correlate with the number 
Abstract 
Aims This prospective study focuses on risk factors for 
arterial damage in children with type 1 diabetes (T1D).
Methods Eighty children and adolescents with T1D 
were investigated twice, approximately 2 years apart, for 
carotid artery intima-media thickness (cIMT) and compli-
ance (CAC), flow-mediated dilatation (FMD) of the bra-
chial artery, and plasma levels of matrix metalloproteinase 
(MMP)-8. All subjects were genotyped for HLA. The num-
ber of respiratory tract infections (RTI) during the past year 
was obtained by a questionnaire in 56 patients.
Results cIMT progression, defined as percentage (%) 
change of cIMT from baseline, correlated inversely with the 
% changes of both CAC (p = 0.04, r = − 0.3; n = 62) and 
FMD (p = 0.03, r = − 0.3; n = 47). In multivariate analysis, 
RTI frequency correlated significantly with cIMT progres-
sion irrespective of age, diabetes duration, BMI, and HbA1c 
(p = 0.03, r = 0.3). When patients were divided in relation 
to RTI, the association of DQ2/8 with cIMT progression 
remained significant in patients with over three infections/
year (p = 0.04, r = 0.3). During follow-up, the group of 
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of inoculations [9]. Nonetheless, negative studies have been 
reported as well [10].
Atherosclerosis develops faster in children with T1D [11]. 
Several genes within the HLA region encoding antigen-
presenting molecules with role in the autoimmune cascade 
in T1D have been shown to associate with damage to vas-
cular endothelium in vitro [12]. Experimental studies have 
shown that, in an inflammatory milieu, HLA may be quickly 
translocated to endothelial cell surface, thereby contribut-
ing via antigen presentation to intravascular (in arteries) or 
extravasal (in microcirculation) accumulation of T lympho-
cytes [12, 13].
The genetic HLA-related susceptibility is recognized in 
more than 80% of young patients with T1D [14]. We have 
earlier reported in a cross-sectional study of children and 
young adults with T1D that diabetes duration, body mass 
index, and glycosylated haemoglobin were strongly asso-
ciated with brachial artery and cutaneous microvascular 
endothelial dysfunction in patients with HLA-DQ 2/8 but 
not in those without this genotype [15, 16]. The risk of 
endothelial damage seemed to increase further in patients 
with inflammatory activity, suggesting a possible interplay 
between systemic inflammation and HLA in vascular injury.
The HLA-mediated presentation of autoantigens by vas-
cular endothelial cells, a key-event in the transmigration of 
auto reactive T-cells and diabetes development, seems to 
occur systemically [13]. This could perhaps explain previ-
ous findings of elevated levels of endothelial cell activation 
markers in children with genetic risk for T1D before the 
onset of the disease [17].
Serum and plasma matrix metalloproteinase-8 (MMP-
8) levels have been demonstrated to reflect disease sever-
ity and plaque instability in cardiovascular diseases [18]. 
MMP-8 concentrations are increased during acute coronary 
syndrome [19] and in young individuals with subclinical 
atherosclerosis [20].
In the present prospective study, we investigated whether 
DQ2/8, acute infections and plasma MMP-8 concentra-
tions in children and young adults with T1D associate 
with adverse changes in arterial function and intima-media 
thickness.
Materials and methods
Study population
Eighty children and adolescents (37 male and 43 female) 
with age between 8 and 20 (mean age 15) years with T1D 
duration for at least 6 months were recruited from the pae-
diatric outpatient diabetes clinic at the Lund University 
Hospital. All patients were treated with daily insulin injec-
tions. Exclusion criteria were: family history for other major 
cardiovascular risk factors (primary hypercholesterolemia, 
hypertension, premature coronary and cerebrovascular dis-
ease), active smoking, systemic hypertension, asthma and 
allergy. None of the patients were on corticosteroids or other 
type of immunosuppressive medication. All patients were 
followed for 1.40 ± 0.02 years (range 1.1–2.0 years).
Body weight, height, and arterial blood pressure (systolic 
and diastolic) were measured at both visits. Data on demo-
graphic information were collected via questionnaire. Data 
on diabetes duration were obtained from the registry of the 
outpatient diabetes clinic.
Detailed infection history including type and number of 
acute infections during the past year, duration and severity 
of symptoms, medication if any, and time between the lat-
est infection and the ultrasound visits was also determined 
by questionnaire. Acute infection was defined by clinical 
symptoms. Patients were grouped in relation to the number 
of infections during the past year as follows: group 1 = 0 
to 1 infection (low frequency), group 2 = 2 to 3 infections 
(moderate frequency), and group 3 = ≥ 3 infections (high 
frequency).
Patients were also grouped based on the hsCRP levels as 
follows: ≤ 1 and > 1.0 mg/l.
Biochemical analyses
All blood samples were taken in connection with the ultra-
sound examination, and stored at − 80 °C until final analysis. 
High-density lipoprotein (HDL-C), low-density lipoprotein 
(LDL-C) and total cholesterol (TC) were analysed from lith-
ium heparin plasma by enzymatic method (Roche/Hitachi 
912, Roche Diagnostics, Mannheim, Germany). Plasma 
high-sensitivity C-reactive protein (hsCRP) was measured 
by enzyme-linked immunoassay using polyclonal antibodies 
(DACO Diagnostics, Glostrup, Denmark).
HLA genotypes were determined in dried spots of 
peripheral blood by polymerase chain reaction followed 
by  DELFIA® hybridization assay [21]. Briefly, DNA in the 
blood was amplified, and presence of particular alleles was 
determined by a hybridization reaction using allele-specific, 
short oligonucleotides labelled with lanthanide chelates.
Plasma MMP-8 concentration was determined by a time-
resolved immunofluorometric assay (IFMA). The monoclo-
nal MMP-8-specific antibodies 8708 and 8706 (Medix Bio-
chemica, Kauniainen, Finland) were used as capturing and 
detection antibody, respectively. The detection antibody was 
labeled using europium chelate [20]. The assay buffer was 
20 mM Tris–HCl, pH 7.5, containing 0.5 M NaCl, 5 mM 
 CaCl2, 50 μM  ZnCl2, 0.5% BSA, 0.05% sodium azide and 
20 mg/l diethylenetriaminepentaacetic acid. Samples were 
diluted 1:5 (vol:vol) in the assay buffer and incubated for 
1 h, followed by incubation for 1 h with the detection anti-
body. Enhancement solution was added and fluorescence 
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was measured after 5 min using a 1234 Delfia Research 
Fluorometer (Wallac, Turku, Finland). The inter-assay coef-
ficient of variation was 7.3% (n = 28). The detection limit 
for the assay was 0.08 ng/ml.
Carotid artery intima‑media thickness and compliance
A high-resolution ultrasound system (Acuson Sequoia C512, 
Siemens AG, Germany) equipped with a 15 MHz probe was 
used [31]. Longitudinal scans in bi-dimensional mode of the 
1-cm-long distal end of the left common carotid artery were 
imaged so that the lumen-intima and media-adventitia inter-
faces were distinguishable. All images corresponded to the 
R-wave on electrocardiogram (ECG). Four scans obtained 
from each individual were recorded on videotape for offline 
analysis of carotid intima-media thickness (cIMT). Two 
sonographers unaware of the infection and genetic status 
carried out the ultrasound examination. The mean cIMT was 
measured from each scan manually. cIMT obtained from all 
scans from the same subject were averaged and the resulted 
mean cIMT was used for statistical analyses. The percent 
change of cIMT (% cIMT) was calculated. Carotid artery 
compliance (CAC) was calculated according to the following 
formulas: CAC = ([Ds − Dd]/Dd)/(Ps − Pd), where Ds is sys-
tolic diameter, Dd is diastolic diameter, Ps is systolic blood 
pressure, and Pd is diastolic blood pressure. CAC reflects the 
ability of arteries to expand in response to the pulse pres-
sure caused by cardiac contraction and relaxation. In a prior 
reproducibility study on 10 randomly selected patients, the 
coefficient of inter-observer variability was 6.2%.
Flow‑mediated dilatation
Longitudinal scans of the brachial artery (non-dominant 
arm) were imaged several centimetres above the antecubital 
fossa via a 15-MHz linear ultrasound transducer of an Acu-
son  Sequoia™ C512 (Siemens AG, Germany) [32]. The ultra-
sound beam frequency was set at 8 MHz. Once the image 
was obtained, the transducer was positioned throughout the 
ultrasound study with aid of a transducer arm. ECG-gated 
end-diastolic scans of the artery were recorded at baseline, 
and a pressure cuff tourniquet placed around the forearm 
was thereafter inflated to 200 mmHg (minimum 50 mmHg 
over the systolic blood pressure) for 5 min. A new series of 
frames were taken for 15 s before and 120 s after cuff defla-
tion. Following a 10-min recovery period, additional frames 
were taken before and over a 4-min period after sublingual 
administration of 400 µg glycerol trinitrate (GTN spray). 
The latter was used as endothelium-independent vasodilator. 
Flow-mediated and GTN-induced brachial artery dilatations 
were expressed as maximum percent dilatation following 
cuff deflation and GTN administration, respectively.
Statistical analysis
Differences in the studied variables were assessed by 
ANOVA, and adjusted for covariates by ANCOVA. Eventual 
correlations between the hypothesised predictor variables 
and the dependent variable were assessed by logistic regres-
sion. When significant, multiple regression models were 
used to identify independent factors affecting the vascular 
indexes. hsCRP was logarithmically transformed due to its 
skewed distribution. All other numeric variables showed a 
Gaussian distribution. “cIMT progression” was defined as % 
increase in cIMT at 18 months from the baseline. Similarly, 
changes in FMD and CAC over the follow-up period were 
expressed as % change at 18 months from the corresponding 
baseline values.
All data are expressed as mean ± SD unless otherwise 
specified. Statistical significance was accepted when p was 
less or equal to 0.05. All statistical analyses were performed 
with StatView for Windows (version 5.0, SAS Institute, 
USA).
Results
The patients’ main characteristics according to the DQ2/8 
genotype are summarised in Table 1. As shown in Table 1, 
there were no significant differences in the demographic, 
diabetes, and inflammatory variables. There was no correla-
tion between diabetes duration and number of RTI (p = 0.23, 
r = 0.13). Baseline diabetes duration (p = 0.04, r = 0.23) 
and BMI (p = 0.06, r = 0.20), but not HbA1c, had a weak 
association with the final cIMT, but neither of these showed 
a significant correlation with % cIMT (p > 0.2). % cIMT 
correlated inversely with the % changes in CAC (p = 0.04, 
r = − 0.3, n = 62; Fig. 1a) and FMD (p = 0.03, r = − 0.3, 
n = 47; Fig. 1b).
HLA‑DQ 2/8 and vascular changes
% cIMT was increased in the DQ2/8 group compared to the 
non-DQ2/8 group (7.4 ± 12.5 vs. 1.9 ± 7.7, respectively, 
p = 0.02, Fig. 2), whereas % FMD and % CAC were com-
parable in the groups (p > 0.5 for each). The relationship 
between % cIMT and DQ2/8 remained significant after 
simultaneous adjustment for age, BMI, diabetes duration, 
HbA1c, and LDL-to-HDL ratio (p = 0.03 by ANCOVA). 
Although gender alone did not influence % cIMT (male vs. 
female: p = 0.3), % cIMT was most increased in male DQ2/8 
patients (Fig. 3; p = 0.01 vs. female non-DQ2/8 patients; 
p = 0.04 after adjustment for age, BMI, diabetes duration, 
HbA1c, and LDL-to-HDL ratio).
There was no significant difference in MMP-8 concen-
trations between DQ2/8 groups (p = 0.4). MMP-8 levels 
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were significantly higher in those patients with hsCRP ≥ 1 
compared to those with hsCRP  ≤  1at the follow-up 
(p = 0.045). However, only patients positive for DQ2/8 with 
hsCRP > 1 mg/L at follow-up had significantly higher lev-
els of plasma MMP-8 than the non-DQ2/8 patients (Fig. 4). 
With exception of baseline BMI (p = 0.03, r = 0.3) and 
HbA1c (p = 0.04, r = 0.2), which were modestly associ-
ated with final MMP-8, no other variable showed correlation 
with it.
Infection frequency and % cIMT
In a multivariate model adjusted for age, BMI, diabetes dura-
tion, HbA1c, and the number of RTI during the year prior 
to the baseline ultrasound, infection frequency showed a 
significant relationship to % cIMT (Table 2). % cIMT was 
most increased in patients with > 3 RTI/year (Fig. 5a). When 
patients were divided on the basis of the genotype, the cor-
relation between infection frequency and % cIMT remained 
significant only in DQ2/8 patients (Fig. 5b).
Discussion
There is solid evidence for association of T1D with pre-
mature carotid atherosclerosis in childhood [11]. In the 
present study of diabetic children and adolescents with 
and without HLA DQ2/8, we found suggestive evidence 
of accelerated structural changes (expressed as increase 
of % IMT) in those positive for this genotype. Carotid 
artery intima-media thickness increased most significantly 
in DQ2/8 patients that experienced three or more respira-
tory tract infections per year. Of note, the % change of 
cIMT was inversely related to the % change in both CAC 
and FMD. Neither CAC nor FMD did change significantly 
over the study period in relation DQ2/8. Similar to our 
study, Halcox et al. [22] in 2009 found decrease of FMD 
with averaged annual progression of cIMT.
Matrix metalloproteinases (MMPs) are structurally 
related but genetically distinct enzymes that can degrade 
almost all extracellular matrix components. Especially 
MMP-8 or collagenase-2 can also process various non-
matrix bioactive substrates. Due to such decisive substrate 
cleavage(s) MMP-8 can mediate surrogate destructive pro-
inflammatory immune reactions [23–25]. Many inflamma-
tory cells secrete MMPs, which remodel the matrix facilitat-
ing thus the leukocyte traffic through tissues [26]. Among 
DQ2/8 patients, CRP levels > 1 mg/l was associated with 
elevated MMP-8, a biomarker of both systemic inflamma-
tory and intravascular inflammation. In adults, high serum 
MMP-8 is an independent risk factor for incident cardiovas-
cular events [20].
Table 1  Patients’ main 
characteristics in relation to 
HLA-DQ2/8
Data are mean ± SD
NA not applicable
* For lipids and CRP, p value was calculated after adjustment for age, diabetes duration, BMI, and HbA1c
DQ2/8 Non-DQ2/8 p* (For 
base-
line)Baseline Follow-up Baseline Follow-up
Number of patients 32 32 45 45 –
Age (years) 14.7 ± 3.8 15.7 ± 3.8 15.2 ± 3.0 16.2 ± 3.0 0.47
BMI 21.1 ± 3.8 22.1 ± 4.4 21.0 ± 3.1 21.6 ± 3.1 0.90
Diabetes duration (years) 6.5 ± 4.3 7.4 ± 4.3 7.6 ± 4.2 8.7 ± 4.1 0.27
HbA1c (%) 7.0 ± 1.7 7.6 ± 1.6 7.0 ± 1.1 7.3 ± 1.3 0.95
HbA1c (mmol/mol) 53 ± 19 59 ± 18 53 ± 12 56 ± 14 0.95
hsCRP (mg/l) 2.5 ± 4.1 1.4 ± 1.9 1.6 ± 3.1 1.9 ± 2.6 0.20
MMP-8 (ng/ml) NA 27.2 ± 25.1 NA 30.1 ± 57.5 NA
LDL-C (mmol/l) 2.5 ± 1.0 2.5 ± 0.9 2.1 ± 0.7 2.3 ± 1.2 0.06
HDL-C (mmol/l) 1.6 ± 0.4 1.3 ± 0.3 1.6 ± 0.4 1.3 ± 0.5 0.73
LDL/HDL 1.7 ± 0.8 2.0 ± 0.9 1.4 ± 1.1 1.9 ± 0.9 0.27
Total Chol (mmol/l) 4.5 ± 1.1 4.2 ± 1.1 4.1 ± 0.8 3.7 ± 1.4 0.11
cIMT (mm) 0.040 ± 0.006 0.042 ± 0.005 0.040 ± 0.004 0.041 ± 0.004 0.67
cIMT (% change) NA 7.4 ± 12.5 NA 1.9 ± 7.7 0.02
CAC (%/10 mmHg) 2.8 ± 1.7 3.8 ± 1.2 2.8 ± 1.0 3.9 ± 1.8 0.91
CAC (% change) NA 33.6 ± 48.7 NA 26.2 ± 48.7 0.57
FMD (%) 8.1 ± 6.8 6.2 ± 2.0 9.9 ± 7.2 7.0 ± 3.0 0.30
FMD (% change) NA − 23.4 ± 47.1 NA − 17.1 ± 53.1 0.69
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Functional disturbances in the vasculature such as 
endothelial vasomotor dysfunction and decreased arterial 
elasticity are important signs of early vascular disease, and 
associate with arterial intima thickening [27]. In a prior 
cross-sectional study from our centre, higher frequency of 
respiratory tract infections in T1D was linked to impaired 
carotid artery elasticity especially in those exposed to pas-
sive tobacco smoking [2]. Infection is a powerful trigger of 
inflammation in the body, being earlier associated to arte-
rial endothelial cell damage and intima-media thickening in 
mice, piglets and children [28–30].
Even children without conventional risk factors for ath-
erosclerosis appear to be prone to carotid artery thicken-
ing already 3 months after an acute infectious illness [31]. 
Acute infections initiate endothelial cell dysfunction in 
children, and the dysfunction is worse in diabetic children 
than in healthy children [31]. In the present study carotid 
artery intima-media thickness increased most significantly 
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Fig. 1  Scatterplot of % change in cIMT and CAC (panel a) and FMD 
(panel b)
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Fig. 2  Box plot illustrating the difference in % cIMT between the 
DQ2/8 and non-DQ2/8 groups. The box plot displays the 25th per-
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centiles as horizontal lines outside the box
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Fig. 3  Bars (mean  ±  SD) illustrating the difference in % cIMT 
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in DQ2/8 patients that experienced three or more respiratory 
tract infections per year. In adults, acute respiratory infec-
tions increased the risk of acute myocardial infarction [32]. 
Symptoms of acute infections associated with increased viral 
and bacterial titres and increased levels of inflammatory 
markers precede acute coronary events [33].
Intuitively, given the upregulatory effects exerted by sys-
temic inflammation on both vascular adhesion molecules 
and HLA molecules, their putative detrimental influences on 
the vascular wall would become stronger in an inflammatory 
environment. In patients with rheumatoid arthritis (RA), 
another cardiovascular risk factor with important genetic 
susceptibility, the mortality from cardiovascular disease was 
most increased in patients with RA-risk HLA and inflam-
matory activity [34].
Future large-scale studies of young patients with T1D 
are needed to confirm these findings and, if proven, to pro-
vide additional mechanistic insights into the putative HLA-
infection interplay on vascular wall. Eventual relationship 
between the observed structural changes and accelerated 
atherosclerosis needs to be investigated as well.
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Table 2  Multivariable 
regression analysis of % change 
in cIMT
Coefficient Std error Std coefficient t-value p value
Intercept 1.852 12.408 1.852 0.149 0.8820
Age (years) − 0.147 0.620 − 0.046 − 0.0238 0.8130
BMI (kg/m2) 0.045 0.0565 0.014 0.080 0.9171
HbA1c (%) − 0.141 1.351 − 0.017 − 0.105 0.9171
Diabetes duration (years) − 0.095 0.435 − 0.039 − 0.219 0.8273
Infection frequency (n) 2.169 0.962 0.325 2.254 0.0285
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Fig. 5  a Differences in % change in cIMT between patients grouped 
in relation to number of respiratory tract infections (RTI) during the 
preceding year. b Correlation between RTI frequency/year and % 
change in cIMT in patients with (black circles) and without HLA-
DQ2/8 (white circles)
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